Regent Pacific Group Limited (RPGLF)
OTCMKTS · Delayed Price · Currency is USD
0.0007
0.00 (0.00%)
At close: Jun 9, 2025
Regent Pacific Group Revenue
In the year 2024, Regent Pacific Group had annual revenue of $719.00K with 147.08% growth. Regent Pacific Group had revenue of $676.00K in the half year ending December 31, 2024, with 569.31% growth.
Revenue
719.00K
Revenue Growth
+147.08%
P/S Ratio
44.47
Revenue / Employee
47.93K
Employees
17
Market Cap
31.98M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 719.00K | 428.00K | 147.08% |
| Dec 31, 2023 | 291.00K | 177.00K | 155.26% |
| Dec 31, 2022 | 114.00K | -3.14M | -96.50% |
| Dec 31, 2021 | 3.25M | 1.58M | 94.85% |
| Dec 31, 2020 | 1.67M | 1.51M | 918.29% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Elite Pharmaceuticals | 84.04M |
| Glass House Brands | 215.62M |
| Northwest Biotherapeutics | 1.47M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |